(Q30582479)

25 June 2017

1 reference

title

Clinical use of brain volumetry (English)

1 reference

25 June 2017

2

Nicola De Stefano

1 reference

25 June 2017

Antonio Giorgio

1

1 reference

25 June 2017

publication date

1 January 2013

1 reference

Journal of Magnetic Resonance Imaging

25 June 2017

published in

1 reference

25 June 2017

volume

37

1 reference

25 June 2017

issue

1

1 reference

25 June 2017

page(s)

1-14

1 reference

Revising the definition of Alzheimer's disease: a new lexicon.

25 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Mild cognitive impairment: clinical characterization and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

New research criteria for the diagnosis of Alzheimer's disease applied in a memory clinic population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Markers of Alzheimer's disease in a population attending a memory clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Clinical application of measurement of hippocampal atrophy in degenerative dementias

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Measurement of basal forebrain atrophy in Alzheimer's disease using MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Patterns of brain atrophy in frontotemporal dementia and semantic dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

21 January 2018

Frontotemporal dementia

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Atrophy patterns in histologic vs clinical groupings of frontotemporal lobar degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Distinct anatomical subtypes of the behavioural variant of frontotemporal dementia: a cluster analysis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Distinct behavioural profiles in frontotemporal dementia and semantic dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Patterns of cortical thinning in the language variants of frontotemporal lobar degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Neuroanatomical correlates of behavioural disorders in dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

The clinical use of structural MRI in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Individual patient diagnosis of AD and FTD via high-dimensional pattern classification of MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Advances in MRI for 'cryptogenic' epilepsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

A randomized, controlled trial of surgery for temporal-lobe epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

MR imaging of epilepsy: strategies for successful interpretation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Hippocampal volumetry and functional MRI of memory in temporal lobe epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

The clinical-pathogenic mechanisms of hippocampal neuron loss and surgical outcomes in temporal lobe epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Focal cortical dysplasia: prevalence, clinical presentation and epilepsy in children and adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Distributional assumptions in voxel-based morphometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Small focal cortical dysplasia lesions are located at the bottom of a deep sulcus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

In vivo profiling of focal cortical dysplasia on high-resolution MRI with computational models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

New and reliable MRI diagnosis for progressive supranuclear palsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Early structural changes in individuals at risk of familial Alzheimer's disease: a volumetry and magnetization transfer MR imaging study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Assessing the onset of structural change in familial Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Tracking atrophy progression in familial Alzheimer's disease: a serial MRI study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

CSF biomarkers and medial temporal lobe atrophy predict dementia in mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

MRI measures of temporoparietal regions show differential rates of atrophy during prodromal AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Visual assessment of atrophy on magnetic resonance imaging in the diagnosis of pathologically confirmed young-onset dementias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-term conversion to AD: results from ADNI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

MRI correlates of neurofibrillary tangle pathology at autopsy: a voxel-based morphometry study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Whole-brain atrophy rate and CSF biomarker levels in MCI and AD: a longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Increased hippocampal atrophy rates in AD over 6 months using serial MR imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

The measurement and clinical relevance of brain atrophy in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Progressive ventricular enlargement in patients with clinically isolated syndromes is associated with the early development of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Pronounced focal and diffuse brain damage predicts short-term disease evolution in patients with clinically isolated syndrome suggestive of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Whole brain volume changes in patients with progressive MS treated with cladribine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Longitudinal brain volume measurement in multiple sclerosis: rate of brain atrophy is independent of the disease subtype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Brain atrophy in clinically early relapsing-remitting multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Evidence of early cortical atrophy in MS: relevance to white matter changes and disability

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Voxel-wise assessment of progression of regional brain atrophy in relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Grey matter loss in relapsing-remitting multiple sclerosis: a voxel-based morphometry study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Regional gray matter atrophy in early primary progressive multiple sclerosis: a voxel-based morphometry study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Focal cortical atrophy in multiple sclerosis: relation to lesion load and disability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Focal thinning of the cerebral cortex in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Thalamic neurodegeneration in relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Thalamic neurodegeneration in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Regional brain atrophy in children with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Gray and white matter volume changes in early RRMS: a 2-year longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Gray matter atrophy in multiple sclerosis: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Eight-year follow-up study of brain atrophy in patients with MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Predicting neuropsychological abnormalities in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Cerebral disconnection in multiple sclerosis. Relationship to atrophy of the corpus callosum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Anterior corpus callosum atrophy and verbal fluency in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

A longitudinal study of callosal atrophy and interhemispheric dysfunction in relapsing-remitting multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Regional hippocampal atrophy in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Evidence for a direct association between cortical atrophy and cognitive impairment in relapsing-remitting MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Regional brain atrophy is associated with physical disability in multiple sclerosis: semiquantitative magnetic resonance imaging and relationship to clinical findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Voxel-based morphometry of temporal lobe epilepsy: an introduction and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Hippocampal and thalamic atrophy in mild temporal lobe epilepsy: a VBM study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Voxel-based morphometric comparison of hippocampal and extrahippocampal abnormalities in patients with left and right hippocampal atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Temporal lobe developmental malformations and epilepsy: dual pathology and bilateral hippocampal abnormalities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

No change in the structure of the brain in migraine: a voxel-based morphometric study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Evaluation of cerebellar and cerebral volume in migraine with aura: a stereological study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Brain gray matter changes in migraine patients with T2-visible lesions: a 3-T MRI study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Thickening in the somatosensory cortex of patients with migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

New insights into migraine: application of functional and structural imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Gray matter decrease in patients with chronic tension type headache.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Neuronal plasticity: increasing the gain in pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Chronic pain may change the structure of the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Ubiquitin immunohistochemistry suggests classic motor neuron disease, motor neuron disease with dementia, and frontotemporal dementia of the motor neuron disease type represent a clinicopathologic spectrum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

The present and the future of neuroimaging in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Corpus callosum involvement is a consistent feature of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Measurement of brain atrophy in subcortical vascular disease: a comparison of different approaches and the impact of ischaemic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Cortical changes in cerebral small vessel diseases: a 3D MRI study of cortical morphology in CADASIL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Brain volume changes in CADASIL: a serial MRI study in pure subcortical ischemic vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Structural and metabolic brain abnormalities in preclinical cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Cortical neuronal apoptosis in CADASIL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Hippocampal volume is an independent predictor of cognitive performance in CADASIL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Effect of tramiprosate in patients with mild-to-moderate Alzheimer's disease: exploratory analyses of the MRI sub-group of the Alphase study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Randomized, Placebo-Controlled Trial of the Effects of Donepezil on Neuronal Markers and Hippocampal Volumes in Alzheimer’s Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Does donepezil treatment slow the progression of hippocampal atrophy in patients with Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Longitudinal MRI findings from the vitamin E and donepezil treatment study for MCI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Subregional neuroanatomical change as a biomarker for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Rate of brain atrophy in relapsing MS decreases during treatment with IFNbeta-1a.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Cerebral atrophy and disability in relapsing-remitting and secondary progressive multiple sclerosis over four years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Interferon beta-1a in primary progressive MS: an exploratory, randomized, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis. European Study Group on Interferon beta-1b in secondary progressive multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Glatiramer acetate (Copaxone) treatment in relapsing-remitting MS: quantitative MR assessment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Measurement error of two different techniques for brain atrophy assessment in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Brain atrophy assessment in multiple sclerosis: importance and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Reducing the impact of white matter lesions on automated measures of brain gray and white matter volumes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

CLADA: cortical longitudinal atrophy detection algorithm

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Widespread sensorimotor and frontal cortical atrophy in Amyotrophic Lateral Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Individual voxel-based analysis of gray matter in focal cortical dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Regional brain atrophy development is related to specific aspects of clinical dysfunction in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Brain atrophy and lesion load in a large population of patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Towards a neuroimaging biomarker for amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Interferon beta-1a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

Evidence of thalamic gray matter loss in pediatric multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.23671

21 January 2018

Identifiers

DOI

10.1002/JMRI.23671

1 reference

25 June 2017

1 reference